Cargando…
Correction: Calcium dobesilate reduces VEGF signaling by interfering with heparan sulfate binding site and protects from vascular complications in diabetic mice
Autores principales: | Njau, Florence, Shushakova, Nelli, Schenk, Heiko, Wulfmeyer, Vera Christine, Bollin, Robin, Menne, Jan, Haller, Hermann |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7743950/ https://www.ncbi.nlm.nih.gov/pubmed/33326477 http://dx.doi.org/10.1371/journal.pone.0244353 |
Ejemplares similares
-
Calcium dobesilate reduces VEGF signaling by interfering with heparan sulfate binding site and protects from vascular complications in diabetic mice
por: Njau, Florence, et al.
Publicado: (2020) -
Calcium dobesilate reduces SARS-CoV-2 entry into endothelial cells by inhibiting virus binding to heparan sulfate
por: Kiyan, Yulia, et al.
Publicado: (2022) -
Author Correction: Calcium dobesilate reduces SARS-CoV-2 entry into endothelial cells by inhibiting virus binding to heparan sulfate
por: Kiyan, Yulia, et al.
Publicado: (2023) -
Calcium Dobesilate Modulates PKCδ-NADPH Oxidase- MAPK-NF-κB Signaling Pathway to Reduce CD14, TLR4, and MMP9 Expression during Monocyte-to-Macrophage Differentiation: Potential Therapeutic Implications for Atherosclerosis
por: Njau, Florence, et al.
Publicado: (2021) -
Molecular Mechanisms and Treatment Strategies in Diabetic Nephropathy: New Avenues for Calcium Dobesilate—Free Radical Scavenger and Growth Factor Inhibition
por: Haller, Hermann, et al.
Publicado: (2017)